glp-1 advantage book The Solution | by Gianna Beasley | Official Publisher Page GLP1 Receptor Agonists—Effects beyond Obesity
Description
For patients requiring additional glycaemic control, the dose may be increased to 2 mg once weekly after at least four weeks at the 1 mg dose

Additionally, reduced food intake and slower nutrient absorption may lower blood volume slightly, making your inner ear and balance centers more sensitive to position changes

It can form what we call a bezoar, or a fiber brick, in the gut, leading to painful bloating and gas

D-Ala2-GIP-glu-PAL is neuroprotective in a chronic Parkinson's disease mouse model and increases BNDF expression while reducing neuroinflammation and lipid peroxidation
GLP-1s work by balancing the hormones in the body that make you feel full or hungry

Rather than incentivizing new medicines, patents now primarily drive the adoption of a profit-focused approach
